Tat-interactive protein 60 consists of an N-terminal chromo barrel domain (TIP60-CB) and a C-terminal acetyltransferase domain and acetylates histone and nonhistone proteins in diverse cellular processes. While TIP60-CB is thought to recognize histone tails, molecular details of this interaction remain unclear. Here, we attempted a quantitative analysis of the interaction between the human TIP60-CB and histone peptides, but did not observe any detectable binding by either fluorescence polarization or isothermal titration calorimetry assays. We also determined the crystal structure of the TIP60-CB alone. Analysis of the apo-structure reveals a putative peptide-binding site that might be occluded by the basic side chain of a residue in a unique b hairpin between the two N-terminal strands of the b barrel, leading to the inability of TIP60-CB to bind histones.
Tat-interactive protein 60 consists of an N-terminal chromo barrel domain (TIP60-CB) and a C-terminal acetyltransferase domain and acetylates histone and nonhistone proteins in diverse cellular processes. While TIP60-CB is thought to recognize histone tails, molecular details of this interaction remain unclear. Here, we attempted a quantitative analysis of the interaction between the human TIP60-CB and histone peptides, but did not observe any detectable binding by either fluorescence polarization or isothermal titration calorimetry assays. We also determined the crystal structure of the TIP60-CB alone. Analysis of the apo-structure reveals a putative peptide-binding site that might be occluded by the basic side chain of a residue in a unique b hairpin between the two N-terminal strands of the b barrel, leading to the inability of TIP60-CB to bind histones.
Keywords: chromo barrel domain; histone methylation; TIP60 Tat-interactive protein 60 (TIP60), also known as KAT5 or HTATIP, is a MYST (MOZ, YBF2, SAS2, and TIP60) family of acetyltransferase that comprises an Nterminal chromo barrel domain (TIP60-CB) and a Cterminal histone acetyltransferase domain [1] [2] [3] . TIP60 catalyzes acetylation of lysine side chains in various histone [4, 5] and nonhistone [6, 7] proteins, including itself [8] , and plays critical roles in multiple cellular processes, such as chromatin remodeling [5] , transcription [5] , DNA double-strand break (DSB) repair [3, 9] , apoptosis [9] , embryonic stem cell identity [10] , and embryonic development [11] . Abnormal expression of TIP60 is associated with tumorigenesis of several carcinomas, such as lymphomas, head-and-neck, breast [12] , and prostate cancers [13] . Homozygous loss of Tip60 leads to embryonic lethality in mice [11] . So it is beneficial to fully understand the biological functions of TIP60, including its individual domains, such as the chromo barrel domain, and this information would be important to develop target-specific inhibitors in the future [14] .
Several studies have analyzed the interaction between modified histones and TIP60-CB. It was reported that Abbreviations ATM, ataxia telangiectasia mutated; DSB, double-strand break; ERa, estrogen receptor alpha; FP, fluorescence polarization; ITC, isothermal titration calorimetry; MBT, malignant brain tumor; PDB, protein data bank; TIP60, tat-interactive protein 60; b-ME, b-mercaptoethanol.
TIP60-CB recognizes trimethylated lysine at site 9 of histone H3 (H3K9me3), which triggers TIP60 to acetylate and activate ataxia telangiectasia-mutated (ATM) kinase, thereby promoting the DSB repair pathway [3] . Phosphorylation of tyrosine 44 of TIP60 reportedly strengthens the interaction between TIP60-CB and H3K9me3 and enhances the activity of TIP60, again facilitating the DSB repair pathway [2] . According to another study, TIP60-CB binds to monomethylated lysine at site 4 of histone H3 (H3K4me1), which stabilizes TIP60 recruitment to a subset of estrogen receptor alpha (ERa) target genes, and then facilitates regulation of the associated gene transcription [1] .
Based on the published reports of histone binding by the chromo barrel domain of TIP60, we aimed at characterizing the interaction between human TIP60-CB and histone peptides by quantitative binding assays and crystallographic analysis. In this study, we used quantitative fluorescence polarization (FP) and isothermal titration calorimetry (ITC) to analyze the interactions between TIP60-CB and histone peptides, however, we could not detect any obvious binding. We attempted to cocrystallize TIP60-CB with its reported partners and only solved the peptide unbound structures. Analysis of the TIP60-CB apo-structure and comparison with published structures of other chromo barrel domains, reveal potential reasons for our failure to detect histone binding in solution or to determine a cocrystal structure of the TIP60-CB in complex with a histone peptide.
Materials and methods

Protein expression and purification
The chromo barrel domain of TIP60 (residues 1-80) was subcloned into a modified pET28-MHL vector. The encoded N-terminal His-tagged fusion protein was overexpressed in Escherichia coli BL21 (DE3) Codon plus RIL (Stratagene, La Jolla, CA, USA) cells under induction of 0.25 mM IPTG at 15°C for 20 h on a shaker at 180 r.p.m. The cells were harvested by centrifugation at 12 227 g at 4°C for 10 min and stored in À80°C.
The frozen cell pellets were thawed and resuspended in 200 mL lysis buffer containing 20 mM Tris, pH 7.5, 500 mM NaCl, 5 mM b-mercaptoethanol (b-ME), and 5% glycerol, and lysed by sonication at power 8.5, 10 min with 10 s on and 10 s off pulse. After sonication, the crude cell extract was centrifuged at 38 400 g at 4°C for 1 h. Then the supernatant was loaded to an open column with 4 mL Ni-nitrilotriacetate resin (Qiagen, Redwood City, CA, USA). After washing with 40 mL washing buffer (20 mM Tris, pH 7.5, 1 M NaCl, 25 mM imidazole), His-tagged fusion protein was eluted with 15 mL elution buffer containing 20 mM Tris, pH 7.5, 250 mM NaCl, 250 mM imidazole. Then, the His-tag was removed by TEV protease treatment overnight at 4°C in dialysis buffer containing 20 mM Tris, pH 7.5, 150 mM NaCl, 5 mM b-ME. The tag-removed protein was further purified by second nickel column and Superdex75 gel-filtration (GE Healthcare, Piscataway, NJ, USA) in the buffer (20 mM Tris, pH 7.5, 150 mM NaCl, 1 mM DTT). The crude protein as well as the purified protein were separated by SDS/PAGE and stained by bromophenol blue. For crystallization experiments, purified protein was concentrated to 20 mgÁmL À1 in a buffer containing 20 mM Tris, pH 7.5, 150 mM NaCl, and 1 mM DTT using Amicon Ultra-15 Centrifugal Filter Units with a molecular weight 3 kDa (Millipore Corporation, Darmstadt, Germany). The molecular weight of the purified protein was determined by mass spectrometry.
In vitro phosphorylation of TIP60-CB
The in vitro phosphorylation of TIP60-CB by c-Abl was performed in a similar way as described previously [2] . In brief, 100 lg purified TIP60-CB was mixed with 5 lg purified c-Abl in a buffer containing 50 mM Tris, pH 8.0, 20 mM MgCl 2 , 10 mM MnCl 2 , 1 mM DTT. The kinase reaction was initialed by the addition of 1 mM ATP and incubated at 25°C for 60 min. Then, the molecular weight of modified sample was determined by mass spectrometry.
Isothermal titration calorimetry (ITC)
All histone peptides were synthesized by Peptide 2.0 Inc. The concentrated proteins were diluted in 20 mM Tris, pH 7.5, and 150 mM NaCl. The lyophilized peptides were dissolved in the same buffer and pH was adjusted by adding NaOH. Peptide concentrations were estimated from the mass of lyophilized material. All measurements were performed at 25°C, using a VP-ITC microcalorimeter (GE Healthcare). Protein with a concentration of 50-100 lM was placed in the chamber, and the peptide with a concentration of 1-2 mM was injected in 25 successive injections with a spacing of 180 s and a reference power of 13 lcalÁs À1 . Control experiments were performed under identical conditions to determine the heat signals that arise from injection of the peptides into the buffer. Data were fitted using the singlesite binding model within the Origin software package (MicroCal, Inc., Westborough, MA, USA).
Fluorescence polarization assay
Peptides were synthesized and purified by Tufts University Core Services (Boston, MA, USA) with fluorescein-labeled C termini. Binding assays were performed in 10 lL at a constant fluorescein-labeled peptide concentration of 40 nM and increasing amounts of protein at concentrations ranging from low to high micromolar in a buffer of 20 mM Tris, pH 7.5, 150 mM NaCl, 1 mM DTT, and 0.01% Triton X-100. All assays were performed in duplicate in 384-well plates, using the Synergy 2 microplate reader (BioTek, Winooski, VT, USA) with an excitation wavelength of 485 nm and an emission wavelength of 528 nm. Data were corrected by background of the free labeled peptides and fitted to the ligand-binding function using GRAPHPAD PRISM 5 (GraphPad, La Jolla, CA, USA) software to determine the K d values.
Crystallization
Purified TIP60-CB (20 mgÁmL À1 ) was mixed with trypsin at 1 : 1000 mass ratio [15] and crystallized using the sitting drop vapor diffusion method at 18°C by mixing 0.5 lL of the protein with 0.5 lL of the reservoir solution. The crystals were obtained in a buffer containing 20% poly(ethylene glycol) 3350 and 0.2 M calcium acetate.
Data collection and structure determination
Diffraction data were collected at low temperature at beam line 19ID of the Advanced Photon Source (Argonne, IL, USA) and reduced with XDS [16] and AIMLESS [17] software. The structure was solved by molecular replacement with the program MOLREP [18] and coordinates extracted and transformed by PHASER [19] from the TIP60 chromo barrel domain solution structure [protein data bank (PDB) code: 2EKO]. The model was automatically retraced with BUCCANEER [20] program using PARROT [21] modified phases. The present model was obtained through iterative manual rebuilding with COOT [22] , restrained refinement under 'local' noncrystallographic symmetry restraints with REFMAC [23] , and model validation with MOLPROBITY [24] . CCP4 [25] , PHENIX [26] , PDB_EXTRACT [27] programs and the IOTBX library [28] were used in preparing model summaries (Table 1) and PDB deposition.
Accession number
Coordinates and structure factor amplitudes of TIP60-CB were deposited in the PDB with accession code 4QQG.
Results and Discussion
Interaction between histone peptides and TIP60-CB not detected by ITC or FP assays
According to previous reports, TIP60-CB binds to H3K9me3 peptide [3] , and the binding is enhanced by phosphorylation at Tyr44 of TIP60 [2] . In order to confirm this, we cloned and purified the TIP60-CB protein from E. coli. In order to obtain phosphorylated TIP60-CB, we treated the TIP60-CB protein by tyrosine kinase c-Abl following the same protocol as reported in the previous study [2] , and the molecular weights of the treated and untreated samples were determined by mass spectrometry. The mass data showed an 80 Da difference in molecular weight of treated and untreated samples (11 812 Da vs 11 732 Da), which is consistent with the theoretical molecular weight difference of the phosphorylated and unphosphorylated samples (Fig. 1A) . However, our ITC assays failed to detect such binding to the H3K9me3 peptide no matter whether TIP60-CB is phosphorylated by tyrosine kinase c-Abl or not (Fig. 1B,C) . TIP60-CB reportedly also binds to H3K4me1 [1] , which we again failed to detect (Fig. 1D) . Furthermore, we screened a library of peptides containing the major methylation modifications on histones H3 and H4, including H3K4/9/27/36me0-me3, H4K20me0-me3, and H3R2 mono-, symmetric, or asymmetric dimethylarginine, against TIP60-CB by the FP assay, an assay we have used to detect both high-affinity binders, such as CW [29] and SGF29 [30] , and low-affinity binders, such as the PWWP proteins [31] , but did not detect any significant interactions (Fig. 1E ). Although our data are in contrast with the studies mentioned above, they are consistent with a previous protein domain microarray assay result that failed to detect any TIP60-CB binding to methylated histone H3 or H4 peptides [32] . There are reports of weak (millimolar) histone peptide binding of the chromo barrel domains of proteins, such as RBBP1 [33] , AtMRG1/2 [34] , and ScEaf3/ MRG15 [35, 36] . For example, the ScEaf3 binding to H3K36me3 is weaker than 1 mM as detected by NMR. In order to further characterize the TIP60-CB binding ability, we increased the protein concentration to ~2 mM from our initial FP screening concentration of 0.5 mM to enhance the binding sensitivity, and used the human homolog MRG15 of ScEaf3 as a positive control. At this higher concentration, we could detect the weak binding of the positive control MRG15 to H3K36me3 (K d > 500 lM), although the binding curve is also not totally saturated yet. On the other hand, even the weak interaction between MRG15 and H3K36me3 could be observed at the 0.5 mM protein concentration, indicating that our protein concentration of~0.5 mM used for the FP binding screening is high enough to detect the potential weak binding affinity of~1 mM. For the TIP60-CB FP data, even at~2 mM of protein concentration, TIP60-CB showed just a weak signal to H3K9me3 or no any sign of binding to H3K4me1 (Fig. 1F) . Taken together, our binding data indicated that the TIP60-CB might bind to H3K9me3 either very weakly or nonspecifically. Of course, it is also possible that TIP60 bind to histone peptides not directly through its chromo barrel domain because the Kaidi and Sun groups [2, 3] used the full-length TIP60 protein purified from mammalian cells in their binding assay. We have tried to purify the full-length TIP60 from both E. coli and insect cells, but could not obtain soluble protein, so it needs further effort to check if the other domains of TIP60 or other subunits of the TIP60 complex may contribute to H3K9me3 binding in the future.
TIP60-CB residues Tyr47 and Phe50 may form an aromatic cage
Even though Momen et al. have released a solution structure of the TIP60 chromo barrel domain under PDB code 2EKO, we have solved the crystal structure of the chromo barrel domain of TIP60 (residues 1-80, Table 1 and Fig. 2 ) as a result of our unsuccessful attempts at preparing a crystal of the domain in complex with a histone peptide. The asymmetric unit of our crystallographic model accommodates seven TIP60 chromo barrel domain molecules and each molecule is highly similar to the solution structure. As expected, coordinates at the termini of the solution structure of TIP60-CB (Momen et al., PDB entry 2EKO) vary significantly between the models of the NMR ensemble. However, coordinates of the loop between the two most C-terminal barrel strands are also distributed broadly across the ensemble, which may have functional implications (Fig. 2A) . This loop includes residue Phe50, which corresponds to residue Trp382 inside the second malignant brain tumor (MBT) repeat of the known histone binder L3MBTL1 (Fig. 2A) . Therein, together with Phe379 and Tyr386, Trp382 forms the aromatic cage that recognizes dimethylated Lys20 of histone H4 [37] . Aromatic cages are formed by between two and four aromatic residues and are a characteristic feature of methylation effector proteins that recognize methylated lysine [38, 39] , methylated arginine [40, 41] , or even N 6 -methyladenosine [42] . Phe379 of L3MBTL1 can be aligned [43] with Tyr47 of TIP60-CB, but the distance between the Ca atoms of Phe379 and Trp382 of L3MBTL1 lies outside and below the 6.1-9.0 A distribution of inter-Ca distances between Tyr47 and Phe50 of TIP60 in the NMR model ensemble (Fig. 2B) . Significant 'loosening' of the putative cage should affect the capability of TIP60-CB to recognize histone peptides, but the wide distribution of distances raises the possibility that even smaller or larger distances are conformationally accessible to TIP60. Like the NMR solution structure (Momen et al., 2007), the protomers of the TIP60-CB crystal structure largely resemble the prototypical DmMOF chromo barrel domain [44] (Fig. 2C) . Electron density resolved residues Tyr47 and Phe50 with varying clarity across the seven protomers (Fig. 2D,E) and suggested that the loop could adopt a conformation similar to the corresponding loop in the second MBT repeat of L3MBTL1, which carries cage residues Phe379 and Trp382.
A possible structural impediment to the binding of the TIP60-CB to lysine-methylated histone peptides
The TIP60-CB, with four b-strands followed by a short 3 10 a-helix, is different from the typical chromo barrel domain comprising a five-strand b-barrel and a long a-helix or a short 3 10 a-helix following these bstrands, such as ScEaf3 [45] , MRG15 [36] , MSL3 [46] , and DmMOF [44] (Figs 2F and 3A) . In addition, TIP60 has a unique b hairpin between the first and second b-strands (Fig. 3B,C) . As mentioned above, the aromatic residues Tyr47 and Phe50 of TIP60-CB may form an aromatic cage, however, a positively charged side chain of Arg17, located in the unique b hairpin, occupies the cage (Fig. 2F) . The Arg17 side chain is not well resolved in the crystal structure (Fig. 2D,E ), but residual difference density indicates that the side chain may compete with a putative histone ligand for space in the aromatic cage (Fig. 3D) . The residue Arg17 can be readily aligned with residue His21 in the MRG15 chromo barrel domain (Fig. 3B) , which has been observed as the obstruction of the aromatic cage by its side chain previously [36] . In addition, the b hairpin, including a long side chain of Gln20, blocks the entrance of the aromatic cage ( Figs 2G and 3D ). ). Negative and positive potentials are depicted in red and blue, respectively. The potential binding cage for the methylated lysine is shown by black circle. Structure figures were generated by using PyMOL (http://pymol.sourcef orge.net). Electrostatic potential surface representations were calculated with PyMOL's built-in protein contact potential function [59] .
As binding of methylated histone peptides has nevertheless been demonstrated for the chromo barrel domains of MRG15 [36] and its yeast homology ScEaf3 [45] , such a binding can also not be ruled out for TIP60-CB, but would likely entail significant movement of the hairpin between the two N-terminal strands of the chromo barrel.
Structural comparison with other chromo barrel domains reveals that all the known histone-binding chromo barrel domains (ScEaf3, MRG15, and MRG2) have a short loop in the potential histone-binding site except MSL3, which has a similar long loop to the b hairpin of TIP60 in its chromo barrel domain (Fig. 3C,E) . However, this loop does not block the histone-binding site and the corresponding residue to Arg17 in MSL3 is Glu21, which is located outside the aromatic cage. In contrast to the positive charged residue, which clashes with the same charged methylated residue, the negative charged residue Glu21 might favor the methylated residue. Compared to the methyllysine complex structure of the chromo barrel domain of ScEaf3, the chromo barrel domain of DmMOF holds an incomplete cage, formed by only one aromatic residue Tyr416, and this incomplete cage is also occupied by a positive charged residue, Arg387 (Fig. 3F) . These two features of DmMOF prevent the binding of methyllysine histone peptides to DmMOF, as reported previously [44] . Taken together, our structural and binding analysis presented here, coupled with the previously published chromo barrel domain structures, reveals that not all of the chromo barrel domains have the histone binding ability.
However, the position of phosphorylation target Tyr44 inside the amino acid sequence implies proximity to the aromatic cage, both solution and crystal structures indicate that the side chain points away from the aromatic cage, consistent with the residue's position on the same b strand as cage residue Tyr47 (Fig. 2F) . Mechanistic insight into the interplay between phosphorylation and putative peptide binding [2] remains elusive.
Structural Comparison of the chromo barrel domain of TIP60 to other Royal family members
The chromo barrel domain reported here is also often called chromodomain or chromodomain-like domain or Tudor-knot domain in the protein domain annotation databases, such as SMART or InterPro, which indicates that the chromo barrel domain also belongs to Royal family domains, made up by chromodomain, Tudor domain, PWWP (Pro-Trp-Trp-Pro) domain, and MBT repeat [47] . Sequence alignment of some chromo barrel domains with the typical chromodomain protein HP1, Tudor domain protein SMN, and MBT repeat protein L3MBTL1 shows that the chromo barrel domain has the highest similarity to the chromodomain, especially for the part of the chrombox homology motif that is used to distinguish the chromodomain form other Royal family members [48] (Fig. 4A) . A large number of the Royal family domain-containing proteins have been reported as methylated lysine and methylated arginine readers [39, 49] . These proteins use a hydrophobic cage, which is formed by two to four aromatic residues, to recognize and bind to the methylated lysine or arginine [38, 39, 50, 51] . Sequence alignment indicates that most cage-forming aromatic residues are highly conserved in Royal family domains (Fig. 4A) . Normally, the histone methylation-binding aromatic cage consists of two to four aromatic and long hydrophobic side chain residues with the cage being accessible to the methyllysine or methylarginine residue. Based on whether a complete and fully functional aromatic cage is present or not, the chromo barrel domain is divided into MOF-like and MSL3-like subgroups, which may bind to RNA and methylated residues, respectively [44] . According to this classification, TIP60 belongs to the MOF-like subgroup, which may not bind to the methylated residues and is consistent with our binding data (Fig. 1) .
Although the sequence alignment suggests high sequence similarity between the chromo barrel domain and Royal family domains, structural comparison shows several structural differences. The common structural core of a Royal family domain is a b-barrellike fold [47] . The complete tertiary structure of a specific Royal family domain is formed by adjoining this common b-barrel-like fold with adjacent b-strands or a-helices. In general, chromo barrel domain is composed of five b-strands and one a-helix [36, 44] , while chromodomain is made up by three b-strands and one a-helix [52] [53] [54] [55] , Tudor domain harbors four to five bstrands [40] , PWWP domain contains five b-strands and one to six a-helices [56] , and MBT, which forms a stable structure unit by using two to four repeats, consists of five b-strands and an extended a-helix arm from its neighbor (Figs 3A and 4B) [37, 57] . The Tudor-knot is named from the Saccharomyces cerevisiae Esa1-knotted Tudor domain, which is formed by the core Tudor domain with extended N-and C-termini forming an antiparallel b-sheet and acting as a knot to help the Tudor domain to interact with RNA [58] . So the Tudor-knot is a special Tudor domain (Fig. 4B) . The chromo barrel domain is also referred to as noncanonical chromodomain because it normally has two more b-strands than the canonical chromodomain, which just has three b-strands and one helix [48] . In addition, although both the chromo barrel domain and the chromodomain share one common structural feature, one a-helix, the a-helix of chromo barrel domain is packed against the b-barrel core in a different direction as chromodomain does (Figs 3A and 4B). Although there are several structural differences, the b-barrel core of chromo barrel domain can superimpose very well with the other Royal family members, which also indicates the chromo barrel domain is a member of the Royal family (Fig. 4C) . Structural comparison also indicates that the extra b-strand (b1) takes over the histone peptide-binding groove of a typical chromodomain, which may explain the weak binding of histone peptide to chromo barrel domain (Fig. 4C ).
In conclusion, our quantitative FP-and ITC-binding assays fail to identify any significant interaction between TIP60 and histone peptides. While the crystal structure of TIP60-CB indicates that the formation of an aromatic cage is possible, it also suggests that access to the cage may be occluded by a basic amino acid side chain within a unique b hairpin. This observation alone does not rule out peptide binding, as such an obstruction may be transient.
